蓝丰生化: 第七届董事会第二十六次会议决议公告

Group 1 - The board of directors of Jiangsu Lanfeng Biological Chemical Co., Ltd. held its 26th meeting on September 3, 2025, via communication methods, with all 8 directors present [1][2] - The board approved the signing of a settlement and debt waiver agreement with Jiangsu Suhua Group Co., Ltd., which is expected to alleviate the company's debt pressure and optimize its asset-liability structure [1] - The agreement does not constitute a related party transaction and does not harm the interests of minority shareholders [1]